Copyright
©2013 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Feb 7, 2013; 19(5): 761-768
Published online Feb 7, 2013. doi: 10.3748/wjg.v19.i5.761
Published online Feb 7, 2013. doi: 10.3748/wjg.v19.i5.761
Preoperative administration of bevacizumab is safe for patients with colorectal liver metastases
De-Bang Li, First Department of General Surgery, First Hospital of Lanzhou University, Lanzhou 730000, Gansu Province, China
Feng Ye, Xiu-Rong Wu, Lu-Peng Wu, Jing-Xi Chen, Bin Li, Yan-Ming Zhou, Department of Hepatobiliary and Pancreatovascular Surgery, First Affiliated Hospital of Xiamen University, Oncologic Center of Xiamen, Xiamen 361003, Fujian Province, China
Author contributions: Li DB, Ye F, and Wu XR participated in the design and coordination of the study, carried out the critical appraisal of studies and wrote the manuscript; Wu LP, Chen JX, and Li B developed the literature search, carried out the extraction of data, assisted in the critical appraisal of included studies and assisted in writing the manuscript; Zhou YM interpreted data, corrected and approve the manuscript; all authors read and approved the final manuscript.
Correspondence to: Yan-Ming Zhou, MD, Department of Hepatobiliary and Pancreatovascular Surgery, First Affiliated Hospital of Xiamen University, Oncologic Center of Xiamen, 55 Zhenhai Road, Xiamen 361003, Fujian Province, China. zhouyms@yahoo.com.cn
Telephone: +86-592-2139708 Fax: +86-592-2137289
Received: August 5, 2012
Revised: November 20, 2012
Accepted: December 25, 2012
Published online: February 7, 2013
Revised: November 20, 2012
Accepted: December 25, 2012
Published online: February 7, 2013
Core Tip